PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12744167-1	2003	This study sought to synthesize a triple helix-forming phosphorothioate oligodeoxynucleotides (TFO-ps) and assess its effects on coagulation activity of the tissue factor(TF) and TF gene expression in endothelial cells.	tfo	95-98	coagulation factor III, tissue factor	Homo sapiens	157-181	
25355395-9	2015	The protein and mRNA expression of TF in the TFO-M+U group was significantly decreased both in vitro and in vivo (P<0.01), as compared with the TFO-M, TFO+U and SSRE groups.	tfo	45-48	coagulation factor III, tissue factor	Homo sapiens	35-37	
25355395-9	2015	The protein and mRNA expression of TF in the TFO-M+U group was significantly decreased both in vitro and in vivo (P<0.01), as compared with the TFO-M, TFO+U and SSRE groups.	tfo	147-150	coagulation factor III, tissue factor	Homo sapiens	35-37	
25355395-9	2015	The protein and mRNA expression of TF in the TFO-M+U group was significantly decreased both in vitro and in vivo (P<0.01), as compared with the TFO-M, TFO+U and SSRE groups.	tfo	147-150	coagulation factor III, tissue factor	Homo sapiens	35-37	
25355395-10	2015	The UTMD-based TFO delivery system promoted the -absorption of TFO and the inhibition of TF, and was therefore considered to be favorable for preventing thrombosis induced by shear stress.	tfo	63-66	coagulation factor III, tissue factor	Homo sapiens	15-17